河北建新化工股份有限公司 董事会审计委员会工作细则 河北建新化工股份有限公司 董事会审计委员会工作细则 第一章 总则 第一条 为强化董事会决策功能，做到事前审计、专业审计，确保董事会对经理 层的有效监督，完善河北建新化工股份有限公司（以下简称"公司"）治理结构， 根据《中华人民共和国公司法》《上市公司治理准则》《上市公司独立董事管理办 法》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》 《河北建新化工股份有限公司章程》（以下简称"《公司章程》"）及其他有关规 定，依据公司股东大会的相关决议，公司特设立董事会审计委员会，并制定本工作 细则。 第二条 董事会审计委员会是董事会按照股东大会决议设立的专门工作机构，主 要负责公司内、外部审计的沟通、监督和核查工作。 第二章 人员组成 第三条 审计委员会成员由三名董事组成，其中两名独立董事，委员中至少有一 名独立董事为会计专业人士。委员会成员应当具备履行审计委员会工作职责的专业 知识和经验，并且应当为不在公司担任高级管理人员的董事。 第四条 审计委员会委员由董事长、二分之一以上独立董事或三分之一以上董事 提名，并由董事会选举产生。 河北建新化工股 ...

河北建新化工股份有限公司 独立董事年报工作制度 第一条 为了进一步提高河北建新化工股份有限公司（以下简称"公司"或 "本公司"）规范运作水平，明确公司独立董事在年报工作中的职责，充分发挥独 立董事在年度报告（以下简称"年报"）编制和披露方面的监督作用，根据《上市 公司独立董事管理办法》《深圳证券交易所上市公司自律监管指引第2号——创业 板上市公司规范运作》《河北建新化工股份有限公司章程》（以下简称"《公司章 程》"）等相关规定，结合公司实际情况，制订本制度。 第二条 公司独立董事应在年报的编制和披露过程中，按照有关法律、行政法 规、规范性文件及《公司章程》等相关规定，切实履行独立董事的责任和义务，勤 勉尽责的开展工作，维护公司整体利益。 第三条 独立董事应督促公司真实、完整、准确地在年报中披露所有应披露的 事项。 第四条 公司董事长为年报沟通机制的第一责任人，公司证劵部为协调部门， 财务部为牵头部门。其中，协调部门负责安排审计委员会、管理层与年审机构沟通 会议的组织、记录、档案保管和日常联络，并为审计委员会开展工作提供必要的资 料和条件；牵头部门负责向审计委员会、年审机构提供沟通会议所需生产经营信息、 财务资 ...

第一章 总则 第一条 为规范河北建新化工股份有限公司（以下简称"公司"）领导人员的产 生，优化董事会组成，完善公司治理结构，根据《中华人民共和国公司法》《上市 公司治理准则》《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监 管指引第2号——创业板上市公司规范运作》《河北建新化工股份有限公司章程》 （以下简称"《公司章程》"）及其他有关规定，依据公司股东大会的相关决议， 公司特设立董事会提名委员会，并制定本工作细则。 第二条 董事会提名委员会是董事会按照股东大会决议设立的专门工作机构，主 要负责对公司董事、总经理及其他高级管理人员的人选、选择标准和程序等事项进 行选择并提出建议。 河北建新化工股份有限公司 董事会提名委员会工作细则 河北建新化工股份有限公司 董事会提名委员会工作细则 本工作细则所称其他高级管理人员，是指公司的副总经理、董事会秘书、财务 负责人。 第二章 人员组成 第三条 提名委员会成员由三名董事组成，其中两名独立董事。 第四条 提名委员会委员由董事长、二分之一以上独立董事或三分之一以上董事 提名，并由董事会选举产生。 选举委员的提案获得通过后，新任委员在董事会会议结束后立即就任。 第五 ...

河北建新化工股份有限公司 董事会薪酬与考核委员会工作细则 河北建新化工股份有限公司 第三条 薪酬与考核委员会成员由三名董事组成，其中两名独立董事。 第四条 薪酬与考核委员会委员由董事长、二分之一以上独立董事或三分之一以 上董事提名，并由董事会选举产生。 选举委员的提案获得通过后，新任委员在董事会会议结束后立即就任。 第五条 薪酬与考核委员会设主任委员一名，由独立董事委员担任，负责主持委 员会工作；主任委员在委员内选举，并报请董事会批准产生。 第六条 薪酬与考核委员会任期与董事会任期一致，委员任期届满，连选可以连 任。期间如有委员不再担任公司董事职务，自动失去委员资格，并由董事会根据上 述第三条至第五条的规定补足委员人数。 董事会薪酬与考核委员会工作细则 第一章 总则 第一条 为进一步健全河北建新化工股份有限公司（以下简称"公司"）董事 （不含独立董事，下同）及高级管理人员的考核和薪酬管理制度，完善公司治理结 构，根据《中华人民共和国公司法》《上市公司治理准则》《上市公司独立董事管 理办法》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运 作》《河北建新化工股份有限公司章程》（以下简称"《公司 ...

Financial Performance - The company's revenue for Q3 2023 was ¥188,276,328.46, representing a 6.73% increase compared to the same period last year, but a 15.46% decrease year-to-date[5]. - Net profit attributable to shareholders for Q3 2023 was ¥2,394,461.14, down 82.10% year-on-year, and year-to-date net profit was ¥10,660,924.99, down 78.10%[5]. - Basic earnings per share for Q3 2023 was ¥0.0043, a decrease of 82.23% compared to the same period last year[5]. - Total operating revenue for the third quarter of 2023 was ¥468,864,747.78, a decrease of 15.4% compared to ¥554,603,019.37 in the same period last year[24]. - Net profit for the third quarter of 2023 was ¥10,660,924.99, a significant decline of 78.1% compared to ¥48,684,942.75 in the previous year[25]. - Total comprehensive income for the third quarter was CNY 10,660,924.99, a decrease from CNY 48,684,942.75 in the previous period[26]. - Basic earnings per share for the current period was CNY 0.0193, down from CNY 0.0882 in the previous period[26]. Assets and Liabilities - The total assets at the end of Q3 2023 were ¥1,627,391,821.02, a decrease of 2.38% from the end of the previous year[5]. - The company's total assets as of September 30, 2023, amounted to ¥1,627,391,821.02, a decrease from ¥1,667,031,573.76 at the beginning of the year[22]. - Current assets totaled ¥803,361,448.25, down 6.3% from ¥857,735,689.79 at the start of the year[21]. - Total current liabilities decreased to ¥137,518,475.00, down 23.9% from ¥180,631,652.19 year-over-year[22]. - The company's equity attributable to shareholders increased slightly to ¥1,461,296,090.28 from ¥1,460,586,134.15[22]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥19,975,348.81, down 83.07% compared to the same period last year[5]. - Net cash flow from operating activities was CNY 19,975,348.81, significantly lower than CNY 117,954,774.43 in the previous period[29]. - Cash inflow from operating activities totaled CNY 314,676,302.29, compared to CNY 417,335,683.50 in the previous period[28]. - Cash outflow from operating activities was CNY 294,700,953.48, slightly decreased from CNY 299,380,909.07 in the previous period[29]. - Net cash flow from investing activities was -CNY 72,605,796.17, an improvement from -CNY 136,580,025.59 in the previous period[29]. - Cash flow from financing activities resulted in a net outflow of -CNY 22,417,814.71, compared to -CNY 133,537,817.01 in the previous period[29]. - The ending balance of cash and cash equivalents was CNY 279,756,654.22, compared to CNY 244,406,730.47 in the previous period[29]. - The company reported a decrease in cash received from sales of goods and services, totaling CNY 291,562,150.20, down from CNY 384,202,030.26[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 24,358[11]. - The largest shareholder, Zhu Shouchan, holds 38.82% of the shares, totaling 215,768,643 shares[11]. - The total number of unrestricted shares held by the top 10 shareholders amounts to 53,942,161 shares for Zhu Shouchan[12]. - The company has a total of 214,985,635 restricted shares at the end of the reporting period[15]. - The top 10 shareholders include Zhu Zairui, Huang Jifen, and Chen Wufeng, with respective holdings of 6.47%, 3.59%, and 1.39%[11]. Stock Options and Incentives - The company plans to adjust the stock option exercise price and the grant price of restricted stock as per the board's resolutions[16]. - A total of 332.72 million stock options can be exercised by 74 incentive objects during the first exercise period from September 14, 2023, to July 10, 2024[18]. - The company completed the cancellation of 497,800 stock options that were granted but not exercised[17]. - The number of stock options granted has been adjusted from 7,258,000 to 6,760,200, accounting for 1.23% of the current total share capital[17]. - The company has 403.75 million restricted stocks that will be listed for trading on September 14, 2023[18]. Other Financial Metrics - The company experienced a 15.46% decline in total revenue year-to-date, primarily due to a decrease in sales prices of main products[8]. - Investment income for Q3 2023 decreased by 70.23% to ¥420,116.15, attributed to reduced returns from wealth management investments[9]. - The net cash flow from financing activities decreased by 83.21% year-to-date, mainly due to reduced guarantee margin expenditures and lower dividends[9]. - The company reported a significant increase in trading financial assets by 88.50% to ¥37,700,000.00 due to increased bank wealth management investments[8]. - Research and development expenses for the third quarter were ¥23,572,388.53, a decrease of 8.8% compared to ¥25,856,533.48 in the previous year[25]. Audit Status - The company has not undergone an audit for the third quarter report[31].

证券代码：300107 证券简称：建新股份 公告编号：2023-050 公司董事会将督促承诺人严格遵守承诺，并按照《中华人民共和国公司法》 《中华人民共和国证券法》以及证监会、深圳证券交易所相关法律法规的规定， 及时履行信息披露义务。 未来十二个月不减持公司股份的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）近日收到控股股东、实际 控制人朱守琛先生出具的《关于自愿不减持公司股份的承诺函》，现将相关情况 公告如下： 基于对公司未来发展前景的信心及公司价值的认可，为支持公司持续、稳定、 健康发展，增强广大投资者信心，公司控股股东、实际控制人朱守琛先生自愿承 诺，自承诺函签署之日起 12 个月内（2023 年 10 月 16 日至 2024 年 10 月 15 日） 不减持其所持有的公司股份；在上述承诺期间内，承诺主体因公司发生资本公积 转增股本、派送股票红利、配股、增发等事项取得的新增股份亦遵守上述承诺。 截至本公告披露日，控股股东、实际控制人朱守琛先生持有公司股份 215,768,643 股，占公司总股本比例为 ...

证券代码：300107 证券简称：建新股份 公告编号：2023-049 河北建新化工股份有限公司 关于 2022 年股票期权与限制性股票激励计划 之股票期权第一个行权期采用自主行权的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、公司 2022 年股票期权与限制性股票激励计划股票期权代码：036503，期 权简称：建新 JLC3。 2、本次符合行权条件的 74 名激励对象在第一个行权期可行权 332.72 万份 股票期权，行权价格为 5.39 元/份。 3、本次行权拟采用自主行权模式，实际可行权期限为 2023 年 9 月 14 日至 2024 年 7 月 10 日。 4、本次可行权期权若全部行权，公司股份仍具备上市条件。 河北建新化工股份有限公司（以下简称"公司"）于 2023 年 7 月 11 日召开 的第六届董事会第二次会议、第六届监事会第二次会议，审议通过了《关于 2022 年股票期权与限制性股票激励计划之股票期权第一个行权期行权条件成就的议 案》。根据 2022 年第一次临时股东大会的相关授权，公司董事会将按照相关规 定办 ...

证券代码：300107 证券简称：建新股份 公告编号：2023-048 河北建新化工股份有限公司 2022 年股票期权与限制性股票激励计划之限制性股票第一个归 属期归属结果暨股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 1、本次归属股票数量：403.75 万股，占归属前公司总股本的比例为 0.73%。 2、本次归属股票上市流通时间：2023 年 9 月 14 日。 4、授予数量（调整前）：公司向激励对象授予 819.50 万股限制性股票 3、本次限制性股票归属条件的激励对象共计 23 人。 4、本次限制性股票归属股票来源：公司向激励对象定向发行公司 A 股普通 股。 河北建新化工股份有限公司（以下简称"公司"）于 2023 年 7 月 11 日召开第 六届董事会第二次会议、第六届监事会第二次会议，审议通过了《关于 2022 年 股票期权与限制性股票激励计划之限制性股票第一个归属期归属条件成就的议 案》。近日，公司办理了 2022 年股票期权与限制性股票激励计划之限制性票第 一个归属期归属股份的登记工作，现将相关事项公 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥280,588,419.32, a decrease of 25.81% compared to ¥378,201,946.89 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥8,266,463.85, down 76.59% from ¥35,305,761.32 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥6,231,636.07, representing an 81.59% decrease from ¥33,849,539.65 in the same period last year[22]. - The net cash flow from operating activities was ¥17,752,153.65, a decline of 76.19% compared to ¥74,547,016.06 in the previous year[22]. - Basic earnings per share were ¥0.0150, down 76.56% from ¥0.0640 in the same period last year[22]. - The total profit for the period was 9.69 million yuan, down 75.69% year-on-year[34]. - The company reported a significant increase in trading financial assets to ¥30,540,000.00, up from ¥20,000,492.46, representing 1.89% of total assets[47]. - The total revenue for the first half of 2023 was 85 million RMB, representing a 67% increase compared to the same period last year[59]. - The net profit for the first half of 2023 reached 3 million RMB, with a significant increase of 140% year-on-year[59]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,614,877,774.07, a decrease of 3.13% from ¥1,667,011,929.77 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company were ¥1,444,789,443.52, down 1.08% from ¥1,460,586,134.15 at the end of the previous year[22]. - Cash and cash equivalents decreased to ¥440,926,031.43, accounting for 27.30% of total assets, down from 30.18%[47]. - Accounts receivable dropped to ¥70,357,505.75, representing 4.36% of total assets, down from 6.01%[47]. - Inventory increased to ¥149,012,253.28, now 9.23% of total assets, up from 6.89%[47]. - Fixed assets rose to ¥519,684,356.22, making up 32.18% of total assets, an increase from 29.92%[47]. - Total liabilities decreased to CNY 170,088,330.55 from CNY 206,445,439.61, a reduction of approximately 17.6%[138]. Business Operations - The main business includes the production and sales of benzene-based intermediates, with applications in pharmaceuticals, agrochemicals, dyes, and paper chemicals[30]. - The company has established long-term stable partnerships with global chemical giants, with products sold in over 20 countries and regions[33]. - The company is focusing on optimizing the industrial chain structure and aims to enhance product value through technological advancements[33]. - The company is implementing a strategy of "horizontal expansion and vertical elongation" to drive long-term growth[33]. - The company is leveraging new technologies such as industrial IoT to enhance operational efficiency and product quality[34]. - The company has a complete direct sales system and a stable sales and after-sales service team to ensure customer satisfaction[31]. - The company plans to expand its product offerings in the chemical sector, focusing on new technologies and market segments[51]. - The company is actively involved in the research and development of new products and technologies to enhance its market competitiveness[54]. Investment and Financial Strategy - The company did not engage in any fundraising activities during the reporting period, maintaining a conservative financial strategy[55]. - The company has not reported any significant non-equity investments during the reporting period, reflecting a cautious investment approach[56]. - The company is exploring potential mergers and acquisitions to expand its market presence and product offerings[54]. - The company plans to increase its investment in its wholly-owned subsidiary, Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd., by RMB 100 million, raising its registered capital from RMB 150 million to RMB 250 million[66]. - The company has made strategic investments in new projects, including a capital increase in a subsidiary focused on chemical production[51]. Environmental and Social Responsibility - The company has developed a complete set of wastewater treatment facilities that achieve 80% resource reuse of industrial wastewater, ensuring sustainable development[41]. - The company is committed to increasing its environmental protection investments to comply with stricter regulations in the fine chemical industry[70]. - The company has implemented a self-monitoring plan for environmental emissions, which includes monitoring various pollutants and their discharge limits[87]. - The company emphasizes social responsibility by integrating it into shareholder and employee rights protection, as well as environmental protection[89]. - The company actively participates in community development through public welfare initiatives, including water supply improvements and public lighting installations[91]. Risk Management - The management has highlighted risks related to macro policies and market conditions that may impact future performance[5]. - The company faces macro policy risks but believes its product development strategy aligns with national industrial policy, minimizing such risks[68]. - The company is exposed to market risks due to rising overseas energy prices and high inflation, which may adversely affect its export business[68]. - The company emphasizes the importance of attracting and retaining high-quality technical and management talent to mitigate risks associated with talent shortages[69]. - The company exports a significant portion of its products, making it vulnerable to exchange rate fluctuations, particularly against the US dollar[69]. Shareholder Information - The company did not distribute cash dividends or bonus shares for the half-year period[77]. - The company approved the stock option and restricted stock incentive plan on July 1, 2022, granting 7.258 million stock options to 78 incentive recipients and 8.195 million restricted shares to 23 recipients[79]. - The largest shareholder, Zhu Shouchan, holds 39.11% of the total shares, amounting to 215,768,643 shares, with 161,826,482 being restricted[124]. - The total number of shareholders at the end of the reporting period was 25,232[123]. - The company has a policy that limits the transfer of shares by directors and senior management to no more than 25% of their total holdings each year[118]. Compliance and Governance - The semi-annual financial report for 2023 has not been audited[97]. - The company has adhered to all commitments made regarding equity incentives and related party transactions[1][2]. - The company has not engaged in any asset or equity acquisitions or sales during the reporting period[100]. - The company has not reported any entrusted loans in the current reporting period[61]. - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[71].

证券代码：300107 证券简称：建新股份 公告编号：2023-043 董 事 会 二〇二三年八月十七日 第六届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）第六届董事会第三次会议 于2023年8月17日在公司会议室以现场结合通讯方式召开。会议通知于2023年8 月7日以书面及通讯的方式发出，本次会议应出席董事9人，实际出席董事9人， 会议由公司董事长朱守琛先生主持。公司全体监事、部分高级管理人员列席了会 议。会议的召集、召开、表决程序符合《中华人民共和国公司法》和《公司章程》 的规定。会议经全体董事表决，通过以下事项： 审议通过了《关于<2023年半年度报告>及其摘要的议案》 董事会认为，《2023年半年度报告》及其摘要的内容能够真实、准确、完整 地反映公司经营情况，不存在虚假记载、误导性陈述或重大遗漏。 公司《2023年半年度报告》及其摘要，详见同日披露于中国证监会指定的创 业板上市公司信息披露网站巨潮资讯网(www.cninfo.com.cn)的公告。 本议案以同意9票，反对0票，弃 ...